Gender disparities in time-to-initiation of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: a Danish nationwide cohort study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gender disparities in time-to-initiation of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: a Danish nationwide cohort study
Authors
Keywords
-
Journal
Cardiovascular Diabetology
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-12-10
DOI
10.1186/s12933-022-01713-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gender Disparities in Aorto-iliac Revascularization in Patients with Aortoiliac Occlusive Disease
- (2022) Austin J. Allen et al. ANNALS OF VASCULAR SURGERY
- Gender Disparities In Heart Failure Related Mortality Rates Among Older Adults; Data From CDC Wonder 1999-2019
- (2022) Abdul Mannan Khan Minhas et al. JOURNAL OF CARDIAC FAILURE
- Cohort profile: Health in Central Denmark (HICD) cohort - a register-based questionnaire survey on diabetes and related complications in the Central Denmark Region
- (2022) Lasse Bjerg et al. BMJ Open
- Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys
- (2021) Giulia Ferrannini et al. Cardiovascular Diabetology
- Adherence to Study Drugs
- (2021) Sofia Sederholm Lawesson et al. CIRCULATION
- Sex, Permanent Drug Discontinuation, and Study Retention in Clinical Trials
- (2021) Emily S. Lau et al. CIRCULATION
- The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitus
- (2021) Michelle L. O’Donoghue et al. DIABETOLOGIA
- The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial
- (2021) Clare Arnott et al. DIABETES OBESITY & METABOLISM
- Gender difference in the association between TyG index and subclinical atherosclerosis: results from the I-Lan Longitudinal Aging Study
- (2021) Ya-Wen Lu et al. Cardiovascular Diabetology
- Trends in Clinical Characteristics and Prescribing Preferences for SGLT2 Inhibitors and GLP-1 Receptor Agonists, 2013–2018
- (2020) Chintan V. Dave et al. DIABETES CARE
- The DIVE/DPV registries: evolution of empagliflozin use in clinical practice in Germany
- (2020) Peter Bramlage et al. BMJ Open Diabetes Research & Care
- Real‐world use of cardioprotective glucose‐lowering drugs in patients with type 2 diabetes and cardiovascular disease: A Danish nationwide cohort study, 2012 to 2019
- (2020) Kristian L. Funck et al. DIABETES OBESITY & METABOLISM
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial
- (2019) Lawrence A. Leiter et al. Cardiovascular Diabetology
- Use of Guideline-Recommended Risk-Reduction Strategies Among Patients with Diabetes and Atherosclerotic Cardiovascular Disease: Insights from Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD)
- (2019) Suzanne V. Arnold et al. CIRCULATION
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Effects of sodium‐glucose co‐transporter‐2 inhibitors in type 2 diabetes in women versus men
- (2019) Karin Rådholm et al. DIABETES OBESITY & METABOLISM
- 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2019) John B. Buse et al. DIABETOLOGIA
- Does type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men?
- (2019) Morten Malmborg et al. EUROPEAN HEART JOURNAL
- Empagliflozin in women with type 2 diabetes and cardiovascular disease – an analysis of EMPA-REG OUTCOME®
- (2018) Bernard Zinman et al. DIABETOLOGIA
- Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETES CARE
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
- (2018) Adrian F Hernandez et al. LANCET
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
- (2017) Aidin Rawshani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Real-world use and modeled impact of glucose-lowering therapies evaluated in recent cardiovascular outcomes trials: An NCDR® Research to Practice project
- (2017) Suzanne V Arnold et al. European Journal of Preventive Cardiology
- Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis
- (2017) Kåre I Birkeland et al. Lancet Diabetes & Endocrinology
- Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events
- (2017) Kenneth W. Mahaffey et al. CIRCULATION
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Positive predictive value of cardiac examination, procedure and surgery codes in the Danish National Patient Registry: a population-based validation study
- (2016) Kasper Adelborg et al. BMJ Open
- Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study
- (2016) Jens Sundbøll et al. BMJ Open
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Danish National Patient Registry: a review of content, data quality, and research potential
- (2015) Morten Schmidt et al. Clinical Epidemiology
- Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences
- (2013) Rajiv Chowdhury et al. EUROPEAN HEART JOURNAL
- Existing data sources for clinical epidemiology: The Danish National Database of Reimbursed Prescriptions
- (2012) Sigrun Alba Johannesdottir et al. Clinical Epidemiology
- Full Coverage for Preventive Medications after Myocardial Infarction
- (2011) Niteesh K. Choudhry et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started